Function, structure and therapeutic potential of complement C5a receptors.
P N Monk1, A-M Scola, P Madala
1Academic Neurology Unit, School of Medicine and Biomedical Science, University of Sheffield, Sheffield, UK. p.monk@shef.ac.uk
British Journal of Pharmacology
|July 3, 2007
Summary
Complement fragment C5a, a pro-inflammatory molecule, interacts with receptors C5aR and C5L2. Research highlights C5aR as a therapeutic target for various conditions beyond immunity.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Complement fragment C5a is a pro-inflammatory mediator generated during complement cascade activation.
- It binds to C5a receptors (C5aR and C5L2) found on immune and other cell types.
- While known for inflammatory roles, C5a's broader physiological functions are increasingly recognized.
Purpose of the Study:
- To review recent advancements in C5a receptor research.
- To evaluate C5aR as a potential therapeutic target.
- To discuss the implications of a non-signaling C5a receptor.
Main Methods:
- Utilized receptor knockout mice, antibodies, and receptor antagonists.
- Employed molecular modeling and structure-activity relationship studies.
- Analyzed species-dependent ligand potency on C5aR.
Main Results:
- Significant progress in understanding C5a physiology through various research tools.
- Identified ligand binding sites and activation mechanisms for C5aR.
- C5a implicated in developmental biology, neurodegeneration, tissue regeneration, and hematopoiesis.
Conclusions:
- C5aR represents a promising therapeutic target.
- Further research into C5a and its receptors can yield novel treatments.
- The role of the non-signaling C5L2 receptor warrants further investigation.
Related Concept Videos
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:31Immunoglobulin-like Cell Adhesion Molecules
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
01:30Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
01:25Structure of Cadherins
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins” is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This diversity of cadherins...